Statement on House Passage of Marijuana Banking Bill & Commitments From Judiciary and Leadership to Move MORE Act Forward

Congress Must Do More Than Marijuana Banking Bill Washington, D.C. – Below is a statement from Queen Adesuyi, Policy Coordinator at Drug Policy Alliance’s Office of National Affairs, in response to the House’s passage of the SAFE Banking Act (H.R.1595) and House Judiciary Chairman Jerry Nadler committing to a vote on the MORE Act (H.R.3884/S.2227). […]

Statement on Marijuana ‘Decriminalization’ and Expungement Law Going into Effect in New York

New York, NY – Below is a statement from Melissa Moore, Deputy NY State Director for the Drug Policy Alliance, on the marijuana ‘decriminalization’ and expungement law going into effect today in New York. “The inability of the state legislature and Governor Cuomo to pass comprehensive marijuana legalization means that Black and Latinx individuals remain […]

Statement on Proposed Federal Rule Change that Would Expose MAT Patients to Criminal Investigations

New York, NY – Below is a statement from Lindsay LaSalle, Director of Public Health Law and Policy, Drug Policy Alliance, in response to a new rule proposed by the federal government—more specifically the Substance Abuse and Mental Health Services Administration (SAMHSA)—that would scrap patient confidentiality requirements and expose medication-assisted treatment (MAT) patients to criminal […]

Drug Policy Alliance Proposes Bold Solutions on International Overdose Awareness Day

New York, NY – In recognition of International Overdose Awareness Day (August 31), the Drug Policy Alliance (DPA) is urging policymakers to adopt Bold Solutions to the Overdose Crisis, including innovative harm reduction, drug education, evidence-based treatment and policy solutions in order to make a concerted dent in the overdose crisis, which claimed nearly 70,000 […]

DPA Analysis of 2018 National Survey of Drug Use and Health (NSDUH)

New York, NY – Below is analysis from Sheila Vakharia, PhD, Deputy Director of the Drug Policy Alliance’s Department of Research and Academic Engagement, in response to the 2018 National Survey of Drug Use and Health released today by SAMHSA. Among the findings: Youth rates of marijuana use remain mostly unchanged in recent years, while […]

Statement on Bernie Sanders Adding Safe Consumption Sites to His 2020 Platform

New York, NY – Below is a statement from Maria McFarland Sánchez-Moreno, Executive Director of Drug Policy Action, in response to 2020 presidential contender Sen. Bernie Sanders adding supervised consumption sites to his criminal justice platform. “Senator Bernie Sanders has rightly recognized the life-saving value of supervised consumption sites as a way to curb the […]

Statement on Proposed Trump Administration Rule to Require Drug Testing in Order to Receive Unemployment Benefits

August 15, 2019 – New York, NY – Below is a statement from Maria McFarland Sánchez-Moreno, Executive Director of the Drug Policy Alliance, in response to an attempt by the Trump Administration to require drug testing in order to receive unemployment benefits: “This latest push to require people seeking unemployment benefits to undergo drug testing […]

Statement on New CDC Report Showing Slight Increase in Naloxone Dispensing – But Still Lags Compared to Overall Opioid Prescribing

New York, NY – Below is a statement from Sheila Vakharia, PhD, Policy Manager and Researcher with the Drug Policy Alliance, in response to a new CDC report showing that, in 2018, while naloxone dispensing by pharmacies did increase slightly from 2017, still only one naloxone prescription was dispensed for every 69 high-dose opioid prescriptions. “It is […]

Right Menu Icon